Login / Signup

Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma.

Bingran YuNing ZhangYun FengYong-Fa ZhangTi ZhangLu Wang
Published in: Journal of hepatocellular carcinoma (2023)
The combination of HAIC with TKIs and anti-PD-1 antibodies is an effective and safe therapeutic regimen over TACE-based combination therapy for patients with HCC. A prospective study with a large sample size is required to validate the efficacy and safety of the combination therapy.
Keyphrases
  • combination therapy
  • locally advanced
  • liver metastases
  • radiofrequency ablation
  • low dose
  • radiation therapy
  • chemotherapy induced